Looking forward to our plans for 2021: SGD Pharma starts major Sucy-en-Brie plant development project

I was proud and happy to visit the Sucy-en-Brie plant this week and to meet the very dedicated team in charge of a major revamping of the factory, coordinated by Philippe Dubois (photo). The project, which will last till March 2021, has now broken ground. This Capex, 31 million€ in total, is the biggest SGD Pharma investment since the Saint-Quentin-Lamotte plant construction.

How Does SGD Pharma Envision the Future of the Pharma/Biopharma Industry?

Source: Pharma's Almanac - December 2020 

SGD Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry.

Moulded glass vials secure COVID-19 vaccine supply

4-Dec-2020 - Manufacturing Chemist - https://manufacturingchemist.com/news/article_page/Moulded_glass_vials_s...

Although different materials have been trialled and tested, glass remains the most widely used type of primary container for parenteral drug products, writes Dr Jingwei Zhang, R&D Director, SGD Pharma

Securing the global injectable vial supply with molded glass

Source: Pharmacy & Packaging - December 2020 

Laurent Millet : "Assessed by EcoVadis, SGD Pharma is in the top 10% of its activity sector."

Interview / Laurent Millet - The Pharmaceutical Post Q4 - December 2020

[Breaking news]

We are proud to announce that Saint-Quentin-Lamotte plant, Center of Excellence for Type I glass, has strived to Zero accident this year.

Thank you to everyone at the site for this challenge brilliantly met!